CCL2 and glioblastoma: Moreover, elevated expression of these markers was associated with shorter survival times in GBM patients (Fig. S8B), suggesting that increased CCL2/CCL7 levels may contribute to poor prognosis by promoting TAM recruitment and maintenance.